Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Florian Lordick(Leipzig University), Elizabeth Smyth(National Health Service), Stefano Cascinu(Vita-Salute San Raffaele University), Guillaume Piessen(Centre Hospitalier Universitaire de Lille), Karin Haustermans(Radboud University Nijmegen), Arndt Vogel(Princess Margaret Cancer Centre), Tania Fleitas(Universitat de València), Fátima Carneiro(University of Siena)
Annals of Oncology
July 30, 2022
10.1016/j.annonc.2022.07.004
Cited by 1,367

Related Papers

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
|The Lancet|2010|7.3k
Gastric cancer
|The Lancet|2020|4.8k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k